You have 9 free searches left this month | for more free features.

Pelvic Re Irradiation

Showing 1 - 25 of 8,889

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rectal Cancer, Recurrence, Radiation Toxicity Trial in Aarhus, Oslo (Hyperfractionated external beam radiation)

Completed
  • Rectal Cancer
  • +2 more
  • Hyperfractionated external beam radiation
  • Aarhus, Denmark
  • +1 more
Apr 14, 2023

Tumor Recurrence, Malignant Epithelial Tumor of Vulva, Malignant Epithelial Tumor of Ovary Trial in Pavia (carbon ion radiation

Recruiting
  • Tumor Recurrence
  • +3 more
  • carbon ion radiation therapy
  • Pavia, Pv, Italy
    CNAO
Jul 13, 2022

Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +5 more
  • Re-irradiation
  • (no location specified)
Oct 16, 2023

Breast Cancer, Recurrent Trial in Meldola (Partial breast re-irradiation)

Not yet recruiting
  • Breast Cancer
  • Recurrent
  • Partial breast re-irradiation
  • Meldola, Forlì Cesena, Italy
    UO Radioterapia, IRST IRCCS
Mar 6, 2023

Glioma Trial in Aviano (Pulsed low dose-rate radiotherapy (pLDRT))

Recruiting
  • Glioma
  • Pulsed low dose-rate radiotherapy (pLDRT)
  • Aviano, Pordenone, Italy
    IRCCS-Centro di Riferimento Oncologico (CRO) di Aviano
Sep 20, 2023

Chronic Pelvic Pain Syndrome, Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Chronic Prostatitis Trial (Pelvic floor

Not yet recruiting
  • Chronic Pelvic Pain Syndrome
  • +3 more
  • Pelvic floor re-education using bio-feedback and home training
  • (no location specified)
Oct 30, 2023

Rectal Cancer, Recurrent Trial in Shanghai (Carbon ion radiation therapy DT: 74Gy/20 fractions)

Not yet recruiting
  • Rectal Cancer
  • Recurrent
  • Carbon ion radiation therapy DT: 74Gy/20 fractions
  • Shanghai, Pudong, China
    Shanghai Proton and Heavy ion center
Apr 7, 2023

Locally Advanced Head-and-Neck Cancer Trial in Heidelberg (C12 re-irradiation, Photon re-irradiation)

Recruiting
  • Locally Advanced Head-and-Neck Cancer
  • C12 re-irradiation
  • Photon re-irradiation
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
Nov 2, 2022

Glioblastoma Trial in Strasbourg (Simultaneous-integrated boost with IMRT)

Not yet recruiting
  • Glioblastoma
  • Simultaneous-integrated boost with IMRT
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Dec 7, 2022

Stress Urinary Incontinence, Low Back Pain Trial in Roma (Postural re-education, Spinal mobilization, Perineal Exercises)

Completed
  • Stress Urinary Incontinence
  • Low Back Pain
  • Postural re-education
  • +2 more
  • Roma, Rm, Italy
    Marco Tramontano
Jul 12, 2023

Ependymoma Trial in Memphis, Toronto (radiation, procedure, drug, device)

Active, not recruiting
  • Ependymoma
  • Irradiation
  • +5 more
  • Memphis, Tennessee
  • +1 more
Oct 28, 2022

Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

Active, not recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • Radiation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

High Dose Re-Irradiation Utilizing Advanced Deformable Image

Not yet recruiting
  • Solid Tumor
  • Re-irradiation
  • (no location specified)
Jun 13, 2022

Breast Cancer, Breast Cancer Recurrent Trial (rPBI)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer Recurrent
  • rPBI
  • (no location specified)
Oct 21, 2022

Cancer Patients Receiving Stereotactic Body RTX Trial in Dallas (SBRT)

Recruiting
  • Cancer Patients Receiving Stereotactic Body RTX
  • SBRT
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Aug 25, 2022

Pancreatic Cancer Trial in Shanghai (Re-irradiation with SBRT)

Recruiting
  • Pancreatic Cancer
  • Re-irradiation with SBRT
  • Shanghai, Shanghai, China
    Huojun Zhang
Jan 6, 2022

Intestinal, Haematological and Urinary Toxicity From Pelvic

Active, not recruiting
  • Prostate Cancer
    • Milan, Italy
      IRCCS San Raffaele
    Jan 4, 2023

    Recurrent Glioblastoma Trial (Niraparib, Re-irradiation (re-RT))

    Not yet recruiting
    • Recurrent Glioblastoma
    • (no location specified)
    Dec 23, 2022

    Prostate Cancer Trial in Sherbrooke (Androgen blockade + radiation therapy)

    Active, not recruiting
    • Prostate Cancer
    • Androgen blockade + radiation therapy
    • Sherbrooke, Quebec, Canada
      Centre de Recherche Clinique du CHUS
    May 20, 2022

    Cancer, Brain Metastases, Adult Trial in Copenhagen (Repeated stereotactic radiosurgery)

    Recruiting
    • Cancer
    • Brain Metastases, Adult
    • Repeated stereotactic radiosurgery
    • Copenhagen, Denmark
      Rigshospitalet, University of Copenhagen
    Nov 8, 2021

    Chronic Pelvic Perinal Pain Trial in Nantes (Group 1, Group 2, Group 3 (control group))

    Terminated
    • Chronic Pelvic Perinal Pain
    • Group 1
    • +2 more
    • Nantes, France
      CHU Nantes
    Dec 15, 2022

    Glioblastoma Trial in Boston, New York, Philadelphia (Pembrolizumab, Bevacizumab, Re-irradiation)

    Active, not recruiting
    • Glioblastoma
    • Boston, Massachusetts
    • +4 more
    Dec 7, 2022

    Irradiation Doses < 10 Gy and of Irradiated Bone Volume on

    Recruiting
    • Prostate Carcinoma
    • +6 more
    • Biological investigations
    • Besançon, France
    • +2 more
    Dec 21, 2021

    Metastatic Spine Lesions Trial in New York (single-fraction radiation, MRI and/or CT)

    Active, not recruiting
    • Metastatic Spine Lesions
    • single-fraction radiation
    • MRI and/or CT
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 29, 2021

    Cervical Cancer Trial in China (Paraaortic prophylactic irradiation and pelvic definitive concurrent chemoradiation, Pelvic

    Recruiting
    • Cervical Cancer
    • Paraaortic prophylactic irradiation and pelvic definitive concurrent chemoradiation
    • Pelvic definitive concurrent chemoradiation
    • Hangzhou, Zhejiang, China
    • +6 more
    Jan 24, 2022